K. Suttontyrrell et al., COMMUNICATION DURING THE RECRUITMENT PHASE OF A MULTICENTER TRIAL - THE RECRUITMENT HOTLINE, Controlled clinical trials, 17(5), 1996, pp. 415-422
Citations number
2
Categorie Soggetti
Medicine, Research & Experimental","Pharmacology & Pharmacy
The Bypass Angioplasty Revascularization Investigation (BARI) is a ran
domized trial that compares the safety and efficacy of angioplasty and
bypass surgery in selected patients with multivessel coronary disease
. During recruitment, the Clinical Coordinating Center (CC) required a
n organized manner of responding to the many questions expected from t
he 18 clinical sites. Thus a dedicated telephone line was established
to provide the clinical sites with information quickly and ensure cons
istent dissemination of information. In addition, the hotline function
ed as a backup mechanism for patient randomization in the event of a c
omputer failure at one of the sites. During the first 13 months of rec
ruitment, 1332 calls were received. The average number of daily calls
peaked at 7.3 with 14 calls being the highest in any one day. Calls gr
adually declined as the clinical sites became more familiar with the p
rotocol, data collection forms, and computer systems. Most questions w
ere answered by the data management staff; however a substantial numbe
r (37%) required faculty level input. For questions that could not be
answered immediately, the median time for a return call was 25 min. Th
e BARI hotline was an efficient way to provide accurate and consistent
feedback to all sites and to identify areas that required protocol cl
arification. It allowed rapid identification of differences in protoco
l interpretation across sites so that these variations could be addres
sed. Review of specific questions by the Operations Committee resulted
in decisions on how to apply the protocol to particularly difficult o
r exceptional cases. While the system was labor-intensive, its benefit
s outweighed this disadvantage. Recommended modifications to lower cos
ts would result in a system that could be easily adapted for use in ot
her clinical trials. (C) Elsevier Science Inc.